<DOC>
	<DOCNO>NCT00476021</DOCNO>
	<brief_summary>This study randomize control trial compare 6 month usage rate levonorgestrel-releasing intrauterine device ( LNG-IUD ) insert postplacentally vaginal delivery delay placement 6-8 week postpartum . Given high rate unintended pregnancy United States , particularly postpartum woman , need reliable , effective , long-term contraception IUD postpartum woman . Postplacental insertion intrauterine contraception would help address need . The primary hypothesis study use LNG-IUD 6 month vaginal delivery high woman immediate postplacental insertion compare delayed insertion 6-8 week follow delivery .</brief_summary>
	<brief_title>Postplacental Delayed Insertion Levonorgestrel-releasing Intrauterine Device ( IUD ) After Vaginal Delivery</brief_title>
	<detailed_description>The United States ( US ) high unintended pregnancy rate develop country . Of 6.4 million pregnancy US year , almost half unintended ( 49 % ) . Roughly half ( 22 % pregnancy ) result unintended birth , 20 % pregnancy result abortion . Postpartum woman particularly susceptible , unintended pregnancy rate 10 % -44 % first year postpartum . These unintended pregnancy occur despite recommendation contraceptive method select prior hospital discharge . Given high rate unintended pregnancy United States , particularly postpartum woman , need reliable , effective , long-term contraception IUD postpartum woman . Postplacental insertion intrauterine contraception would help address need . The IUD highly effective underused method postpartum contraception . Although expulsion rate postplacental insertion high interval insertion , benefit highly effective contraception available immediately delivery may outweigh risk expulsion . To date , randomize trial postplacental insertion LNG-IUD United States . One pilot study United States 20 subject receive ultrasound-guided postplacental insertion LNG-IUD show acceptable expulsion rate 10 % infection 10-week follow-up , thus make postplacental insertion LNG-IUD safe study . This study randomize control trial compare 6 month usage rate levonorgestrel-releasing intrauterine device ( LNG-IUD ) insert postplacentally vaginal delivery delay placement 6-8 week postpartum . One hundred sixty-eight woman receive prenatal care Magee-Womens Hospital , Pittsburgh , PA , interested use LNG-IUD contraception enrol pregnancy . The IUD insert within 10 minute delivery placenta woman randomize immediate insertion . Delayed IUD insertion perform first postpartum visit 6-8 week . All subject follow person 6-8 week 6 month delivery . A telephone interview occur 3 month delivery subject . Subjects eligible insertion due post-randomization ineligibility criterion refer primary gynecologist midwife delay IUD placement . They contact phone 3 6 month assess quality life , contraceptive usage , unintended pregnancy rate .</detailed_description>
	<mesh_term>Levonorgestrel</mesh_term>
	<criteria>Age great equal 18 year Greater equal 24 0/7 week pregnant time enrollment Anticipates undergo vaginal delivery Desires use LNGIUD ( Mirena ) postpartum contraception Willing able sign inform consent English Willing comply study protocol Planning undergo schedule cesarean section Allergy either polyethylene levonorgestrel contraindication use LNGIUD Exposure treatment gonorrhea , chlamydia , trichomoniasis pregnancy Presence one leiomyomata great 3 centimeter diameter Uterine anomaly ( repaired septate uterus ) Current cervical cancer carcinoma insitu Desires repeat pregnancy within one year delivery</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>postpartum</keyword>
	<keyword>contraception</keyword>
	<keyword>postplacental IUD</keyword>
	<keyword>intrauterine device</keyword>
</DOC>